New Best Practice Guidelines for the clinical molecular genetic analysis in the Myotonic Dystrophies type 1 and 2, including presymptomatic and prenatal testing, are now available from this site. The guidelines are the result of a best practice meeting held in October 2008. Our thanks to the authors and the meeting participants for their hard work which has resulted in this document.

To access the guidelines, please go to the Best Practice page of this website.

We welcome any comments or feedback about the guidelines. Please address these to the EMQN office (office@emqn.org).